Opportunities in bio-medicine industry of Yuxi, Yunnan Province

1. 1
Bio-medicine Industry of Yuxi
THE INVESTMENT PROMATION & COOPERATION BUREAU OF YUXI
MAY 11, 2017

2. 2
General Information about Yuxi City

3. 3
the nearest city from provincal capital
----a total area of 15,000 km²
----2 districts and 7 counties
----a population of 2.36 million

4. 4
Superior Natural Condition

5. 5
mild climate freshwater resourceplentiful rainfall

6. 6
Fuxian Lake
20.62 billion m³
grade-one
quality water

7. 7
Chengjiang Fossil Site
Cambrian Explosion
----World Natural
Heritage

8. 8
Location Advantages

9. 9
88KM = 1hour drive to Kunming
110KM =Kunming Changshui International Airport
provincial capital
Kunming
Yuxi

10. 10
◆Kunming-Bangkok international highway
◆Pan-Asian railway East line and the Middle line
◆ Gateway leading
to South-East Asia
◆ Important hub of
"One Belt One Road"
Initiative
Pan-Asian
railway
East line
Pan-Asian
railway
Middle line

11. 11
Industry Foundation

12. 12
Key Industries:
Cigarette, mining,
equipment manufacturing,
bio-medicine, and IT

13. 13
◆ 1 national high-tech
industrial development
zone
◆ 6 provincial key
industrial parks
◆ 4 municipal industrial
parks

14. 14
Social Development Level

15. 15
1 university, 2 vocational and technical colleges,
and other 10 colleges

16. 16
Transportation, infrastructure, electric power and
communication facilities

17. 17
GDP in 2016
= RMB 131.19 billion Yuan
= ￡ 14.6 billion
GDP per capital
= RMB 55,389 Yuan
= ￡6183.5
the second highest in Yunnan

18. 18
25 major
pharmaceutical
enterprises
Bio-pharmaceutical
output
=RMB 12 billion
=￡1.34 billion
biologics, chemical
raw material,
chemical agent, TCM,
phytoextraction
Bio-medicine and big health industry

19. 19
Cooperation Projects

20. 20
Walvax Biotechnology Co., Ltd. Cooperation Project

21. 21
Walvax Biotechnology Co., Ltd.
◆ a modern biological pharmaceutical enterprise engaged in R&D, production
and sales of bio-medicine products including vaccines and blood products
◆ employs more than 1,000 staffs
◆ 1 R&D center, 1 vaccine production base with leading bio-medicine R&D
capacity in China
◆ has done 22 national technology research programmes
◆ marketing network covers 30 provinces and cities of China, which includes
more than 2000 counties.

22. 22
◆This progremme plans to build a
pharmaceutical workshop according to
the 2010 GMP standard and WHO
standard
◆focusing on the manufacturing of
new preventive vaccine, Bevacizumab,
PD-1/PD-L1, blood products, Biological
medicine, CAR-T, genetic testing, and
so on.
◆looking for companies and
institutions to work together, to do
the R&D and manufacturing together,
in order to fulfill Chinese huge market
demand of people vaccinum

23. 23
Molecular Diagnostic Reagent Production
Yunnan Huirui Baer Biotechnology Co., Ltd
----focus on the molecular diagnostic reagent production, smart
health care, food testing and health management

24. 24
The project plans to manufacture laboratory diagnostic
standard molecular diagnostic series products

25. 25
The first phase construction has been done. Looking for
enterprise and institutions to speed up the project construction
and industrialization of the results of scientific research
investment: RMB240 million = ￡26.79 million

26. 26
Coenzyme Q10 Products Industrialization
Yuxi Jiankun Biotechnology Co., Ltd
----committed to the comprehensive development and utilization of tobacco
waste
----Annual output: 15 tons of coenzyme Q10 products
----The four terminal products have completed a pilot batch, with industrial
conditions and independent intellectual property rights

27. 27
Looking for partners to build coenzyme Q10 manufacture line with an annual
output of 20 million bottles of coenzyme Q10 soft capsules, 10 million
coenzyme Q10 toothpaste, 6 million bottles of water-soluble coenzyme Q10
series granules, as well as the R&D and manufacturing of other health care
products and cosmetics based on coenzyme Q10.

28. 28
The main raw material for Coenzyme Q10 products----Tobacco
Yuxi----the largest tobacco & cigarette production area in China
investment: RMB500 million = ￡55.8 million

29. 29
Humic acid and fulvic acid products manufacturing
Yunnan High Grade Biotechnology Co. Ltd
an industrial company which specialized in the medicine, health care
products, cosmetics of humic acid and fulvic acid

30. 30
R&D center,
manufacturing
workshop for the
medicine, cosmetics,
and drinks
warehouse
marketing center
the first phase has
been done
looking for partners
to cooperate in the
second and the
third phase

31. 31
Yuxi Biomedical Industry Core Area construction

32. 32
planning area is 53.3 hectares
----the science and technology
research center, development
incubation and manufacturing base
of monoclonal antibody, vaccine
and other bio-medical industry.
"Yuxi Hi-tech Zone Bio-medical
Industrial Park Conceptual
Planning", "Yuxi Bio-medical
Industrial Park Core Area
Construction Detailed Planning"
and building design of the R&D
center, standard production
workshop, logistics center and
conference center are completed.

33. 33
the R&D center

34. 34
Policy Advantages

35. 35
Thank you!